AmnioQuick Duo+ for diagnosis of premature fetal membranes rupture

Accuracy and response time of dual biomarker model of insulin‐like growth factor binding protein‐1/ alpha fetoprotein (Amnioquick duo+) in comparison to placental alpha‐microglobulin‐1 test in diagnosis of premature rupture of membranes

“…Only four recent studies (Ruanphoo and Phupong, Deckmyn et al , AbuFaza et al , and Abdelazim et al ) have been available to reveal the role of Amnioquick duo+ in diagnosing PROM and these recent studies did not compare the accuracy and response time of Amnioquick duo+ with that of PAMG‐1 tests. To the best of our knowledge, our current study is the largest study to date on Amnioquick duo+, and has remained the only study that has compared the diagnostic response time of Amnioquick duo+ and the PAMG‐1 test in women with symptoms, signs, or features suggestive of PROM.…”